NCT05234125 Better Lifestyle Counseling for African American Women During Pregnancy
| NCT ID | NCT05234125 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Chicago |
| Condition | Overweight or Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2022-08-16 |
| Primary Completion | 2026-11-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2022-08-16 with a primary completion date of 2026-11-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this randomized controlled trial is to establish the effectiveness of a culturally targeted and individually tailored behavioral intervention to promote maternal glucose metabolism in African American women.
Eligibility Criteria
Inclusion Criteria: * African American pregnant woman. * Women between 16 and 22 GWs. * Overweight or obese - pregravid Body Mass Index \>25.0 kg/m2. * Singleton gestation. * Established prenatal care at The University of Illinois Hospital \& Health Sciences. * System Obstetric (UIHHSS' OB) clinics. Able to understand, speak and write in English. Exclusion Criteria: * Multiple gestations. * Night-shift work. * Diagnosed sleep disorders. * Known fetal chromosomal or anatomical abnormalities. * Diagnosed mood disorders. * Gestational diabetes in early pregnancy. * Glycated Hemoglobin (HbA1c) ≥ 6.5%. * Hypoglycemic medications. * Stimulant medication or taking a sleeping aid. * Active drug abuse/excessive alcohol intake.
Contact & Investigator
Bilgay Izci Balserak, PhD
PRINCIPAL INVESTIGATOR
University of Illinois at Chicago
Frequently Asked Questions
Who can join the NCT05234125 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Overweight or Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05234125 currently recruiting?
Yes, NCT05234125 is actively recruiting participants. Contact the research team at bilgay@uic.edu for enrollment information.
Where is the NCT05234125 trial being conducted?
This trial is being conducted at Chicago, United States, Chicago, United States.
Who is sponsoring the NCT05234125 clinical trial?
NCT05234125 is sponsored by University of Illinois at Chicago. The principal investigator is Bilgay Izci Balserak, PhD at University of Illinois at Chicago. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.